Usmarapride (SUVN-D4010), a 5-HT4 receptor partial agonist for the potential treatment of Alzheimer's disease: Behavioural, neurochemical and pharmacological profiling-Reference-Cited by-同舟云学术

Usmarapride (SUVN-D4010), a 5-HT4 receptor partial agonist for the potential treatment of Alzheimer's disease: Behavioural, neurochemical and pharmacological profiling

Published:2023-05 Issue: Volume:947 Page:175625
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Nirogi Ramakrishna,Grandhi Venkata Ramalingayya,Medapati Rajeshbabu,Ganuga Narender,Abraham Renny,Thentu Jagadeesh Babu,Palacharla Veera Raghava Chowdary,Petlu Surendra,Srirangavaram Maheshwari,Subramanian Ramkumar,Ravella Srinivasa Rao,Gagginapally Shankar Reddy,Benade Vijay,Jayarajan Pradeep,Mohammed Abdul Rasheed

Publisher

Elsevier BV

Subject

Pharmacology

Reference47 articles.

1. Aducanumab therapy to treat Alzheimer's disease: a narrative review;Beshir;Int. J. Alzheimer's Dis.,2022

2. Effects of serotonin through serotonin1A and serotonin4 receptors on inhibition in the Guinea-pig dentate gyrus in vitro;Bijak;Neuroscience,1997

3. 5-HT4 receptors;Bockaert;Curr. Drug Targets: CNS Neurol. Disord.,2004

4. 5-HT(4) receptors: history, molecular pharmacology and brain functions;Bockaert;Neuropharmacology,2008

5. Mapping of serotonin 5-HT(4) receptor mRNA and ligand binding sites in the post-mortem human brain;Bonaventure;Synapse,2000

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel HDAC inhibitors provide neuroprotection in MPTP-induced Parkinson's disease model of rats;European Journal of Pharmacology;2023-11

2. Anticholinesterase and Serotoninergic Evaluation of Benzimidazole–Carboxamides as Potential Multifunctional Agents for the Treatment of Alzheimer’s Disease;Pharmaceutics;2023-08-19